Pediatric MDD [major depressive disorder]: Sequential Treatment With Fluoxetine and Relapse Prevention
Phase of Trial: Phase III
Latest Information Update: 08 Oct 2015
At a glance
- Drugs Fluoxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 26 Jun 2013 Planned End Date changed from 1 Jan 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 26 Jun 2013 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 27 Feb 2008 New trial record.